Clinical Trial Update: A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

This update indicates MT200605 is in Phase 2 development for acute ischemic stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• MT200605

Snippet

Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING